Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-06-20

Clinical Trial Update: Etoricoxib in Acute Ankle Ligament Sprains [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating etoricoxib for acute ankle sprains has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoricoxib (etoricoxib)

Snippet

Sponsor: University of Cape Town | Conditions: Sprain | Phase 4 | Status: WITHDRAWN